{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T20:51:01Z","timestamp":1771102261724,"version":"3.50.1"},"reference-count":40,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["4800-4837-301"],"award-info":[{"award-number":["4800-4837-301"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1A2B4002827"],"award-info":[{"award-number":["2017R1A2B4002827"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the COVID-19 pandemic in the world. The spike protein of the various proteins encoded in SARS-CoV-2 binds to human ACE2, fuses, and enters human cells in the respiratory system. Spike protein, however, is highly variable, and many variants were identified continuously. In this study, Korean mutants for spike protein (D614G and D614A-C terminal domain, L455F and F456L-RBD, and Q787H-S2 domain) were investigated in patients. Because RBD in spike protein is related to direct interaction with ACE2, almost all researches were focused on the RBD region or ACE2-free whole domain region. The 3D structure for spike protein complexed with ACE2 was recently released. The stability analysis through RBD distance among each spike protein chain and the binding free energy calculation between spike protein and ACE2 were performed using MD simulation depending on mutant types in 1-, 2-, and 3-open-complex forms. D614G mutant of CT2 domain, showing to be the most prevalent in the global pandemic, showed higher stability in all open-complex forms than the wild type and other mutants. We hope this study will provide an insight into the importance of conformational fluctuation in the whole domain, although RBD is involved in the direct interaction with ACE2.<\/jats:p>","DOI":"10.3390\/ijms22168714","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T09:22:38Z","timestamp":1628846558000},"page":"8714","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2"],"prefix":"10.3390","volume":"22","author":[{"given":"Kwang-Eun","family":"Choi","sequence":"first","affiliation":[{"name":"Graduate School of New Drug Discovery and Development, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8240-0395","authenticated-orcid":false,"given":"Jeong-Min","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28159, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JeeEun","family":"Rhee","sequence":"additional","affiliation":[{"name":"Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28159, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ae Kyung","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28159, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6784-8004","authenticated-orcid":false,"given":"Eun-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28159, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam Sook","family":"Kang","sequence":"additional","affiliation":[{"name":"Graduate School of New Drug Discovery and Development, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-70827-z","article-title":"Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide","volume":"10","author":"Isabel","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The architecture of SARS-CoV-2 transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/cr.2016.152","article-title":"Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding","volume":"27","author":"Gui","year":"2017","journal-title":"Cell Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lebeau, G., Vagner, D., Frumence, \u00c9., Ah-Pine, F., Guillot, X., Nob\u00e9court, E., Raffray, L., and Gasque, P. (2020). Deciphering SARS-CoV-2 virologic and immunologic features. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165932"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"588618","DOI":"10.3389\/fmolb.2020.588618","article-title":"ACE2 in the era of SARS-CoV-2: Controversies and novel perspectives","volume":"7","author":"Saponaro","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41586-020-2772-0","article-title":"Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion","volume":"588","author":"Benton","year":"2020","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"583523","DOI":"10.3389\/fmolb.2020.583523","article-title":"Investigation of the effect of temperature on the structure of SARS-Cov-2 Spike Protein by Molecular Dynamics Simulations","volume":"7","author":"Rath","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10822-020-00356-4","article-title":"Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein","volume":"35","author":"Deganutti","year":"2020","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Piplani, S., Singh, P.K., Winkler, D.A., and Petrovsky, N. (2020). In silico comparison of spike protein-ACE2 binding affinities across species; significance for the possible origin of the SARS-CoV-2 virus. arXiv.","DOI":"10.1038\/s41598-021-92388-5"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nelson, G., Buzko, O., Bassett, A., Spilman, P., Niazi, K., Rabizadeh, S., and Soon-Shiong, P. (2020). Millisecond-scale molecular dynamics simulation of spike RBD structure reveals evolutionary adaption of SARS-CoV-2 to stably bind ACE2. bioRxiv, 422055.","DOI":"10.1101\/2020.12.11.422055"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"051008","DOI":"10.1116\/6.0000502","article-title":"Computer Simulations of the interaction between SARS-CoV-2 spike glycoprotein and different surfaces","volume":"15","author":"Malaspina","year":"2020","journal-title":"Biointerphases"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1021\/acs.jpclett.0c01148","article-title":"Is the rigidity of SARS-CoV-2 spike receptor-binding motif the hallmark for its enhanced infectivity? Insights from all-atom simulations","volume":"11","author":"Spinello","year":"2020","journal-title":"J. Phys. Chem. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"He, J., Tao, H., Yan, Y., Huang, S.-Y., and Xiao, Y. (2020). Molecular mechanism of evolution and human infection with SARS-CoV-2. Viruses, 12.","DOI":"10.3390\/v12040428"},{"key":"ref_16","first-page":"v1","article-title":"Exploring the binding mechanism and accessible angle of SARS-CoV-2 spike and ACE2 by molecular dynamics simulation and free energy calculation","volume":"11877492","author":"Peng","year":"2020","journal-title":"Chemrxiv. Org."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13967","DOI":"10.1073\/pnas.2008209117","article-title":"Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions","volume":"117","author":"Wang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","first-page":"154","article-title":"Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development","volume":"12","author":"Singh","year":"2020","journal-title":"J. Lab. Phys."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 Spike: Evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"114493","DOI":"10.1016\/j.molliq.2020.114493","article-title":"Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach","volume":"320","author":"Muhseen","year":"2020","journal-title":"J. Mol. Liq."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1016\/j.csbj.2020.11.002","article-title":"Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization","volume":"18","author":"Shah","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1021\/acs.jcim.0c00679","article-title":"Computational Prediction of Mutational Effects on SARS-CoV-2 Binding by Relative Free Energy Calculations","volume":"60","author":"Zou","year":"2020","journal-title":"J. Chem. Inf. Modeling"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105802","DOI":"10.1016\/j.pep.2020.105802","article-title":"Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays","volume":"179","author":"Mehalko","year":"2021","journal-title":"Protein Expr. Purif."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1021\/acsptsci.0c00161","article-title":"Targeting ACE2\u2013RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay","volume":"3","author":"Hanson","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2020.09.032","article-title":"Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant","volume":"183","author":"Yurkovetskiy","year":"2020","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Miner, J.C., Lappala, A., Fenimore, P.W., Fischer, W.M., McMahon, B.H., Hengartner, N.W., Sanbonmatsu, K.Y., and Tung, C.-S. (2021). Modeling the Influenza A NP-vRNA-Polymerase Complex in Atomic Detail. Biomolecules, 11.","DOI":"10.3390\/biom11010124"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kumari, A., Rajput, V.S., Nagpal, P., Kukrety, H., Grover, S., and Grover, A. (2020). Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin. J. Biomol. Struct. Dyn., 1864476.","DOI":"10.1080\/07391102.2020.1864476"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ortuso, F., Mercatelli, D., Guzzi, P.H., and Giorgi, F.M. (2021). Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike\/human ACE2 complex. J. Biomol. Struct. Dyn., 1886175.","DOI":"10.1101\/2020.09.09.289074"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virol.2021.06.009","article-title":"Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants\u2019 interaction with ACE2 to understand the binding affinity and stability","volume":"561","author":"Verma","year":"2021","journal-title":"Virology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1038\/s41467-020-19808-4","article-title":"SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-020-00439-6","article-title":"Connections between biomechanics and higher infectivity: A tale of the D614G mutation in the SARS-CoV-2 spike protein","volume":"6","author":"Anshumali","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"298a","DOI":"10.1016\/j.bpj.2020.11.1904","article-title":"The SARS-CoV-2 spike variant D614G favors an open conformational state","volume":"120","author":"Mansbach","year":"2021","journal-title":"Biophys. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.24171\/j.phrp.2020.11.1.02","article-title":"Identification of coronavirus isolated from a patient in Korea with COVID-19","volume":"11","author":"Kim","year":"2020","journal-title":"Osong Public Health Res. Perspect."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.24171\/j.phrp.2021.12.1.06","article-title":"Genomic surveillance of SARS-CoV-2: Distribution of clades in the Republic of Korea in 2020","volume":"12","author":"Park","year":"2021","journal-title":"Osong Public Health Res. Perspect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ct900549r","article-title":"Implementation of the CHARMM force field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models","volume":"6","author":"Bjelkmar","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: An N log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"eabb8097","DOI":"10.1126\/sciadv.abb8097","article-title":"Structure-based drug designing and immunoinformatics approach for SARS-CoV-2","volume":"6","author":"Panda","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8714\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:45:36Z","timestamp":1760165136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":40,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijms22168714"],"URL":"https:\/\/doi.org\/10.3390\/ijms22168714","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]}}}